Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K121063
    Date Cleared
    2012-08-21

    (137 days)

    Product Code
    Regulation Number
    892.1550
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    VIVID S5 DIAGNOSTIC ULTRASOUND SYSTEM, VIVID S6 DIAGNOSTIC ULTRASOUND SYSTEM

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The device is intended for use by a qualified physician for ultrasound evaluation of Fetal/Obstetrics; Abdominal/Gynecology; Pediatric; Small Organ (breast, testes, thyroid); Neonatal Cephalic; Adult Cephalic; Cardiac (adult and pediatric); Peripheral Vascular; Musculo-skeletal Conventional and Superficial; Urology (including prostate); Transesophageal; Transrectal; Transvaginal; and Intraoperative (abdominal, thoracic, and vascular).

    Device Description

    The Vivid S5 and Vivid S6 are mobile ultrasound consoles having a wide assortment of electronic array transducers intended primarily for echocardiography with additional capability in vascular and general ultrasound imaging. Its intuitive user interface, high level of auto-optimization along with significantly reduced size and weight make it readily maneuverable, efficient and easy to use.

    AI/ML Overview

    The GE Healthcare Vivid S5/S6 Ultrasound System is a diagnostic ultrasound device intended for various clinical applications. The submission K121063 does not contain acceptance criteria or study data that proves the device meets specific performance metrics. Instead, it is a 510(k) Premarket Notification Submission asserting substantial equivalence to predicate devices. This type of submission relies on demonstrating that the modified device is as safe and effective as a legally marketed device that does not require premarket approval.

    Key points from the submission regarding performance:

    • No new clinical studies were conducted or required. The submission explicitly states: "The subject of this premarket submission, the modified Vivid S5/S6, did not require clinical studies to support substantial equivalence." (Page 2)
    • The device's performance is asserted to be "substantially equivalent to the predicate device(s)." (Page 2)
    • The submission outlines non-clinical tests performed to ensure safety and effectiveness, including acoustic output, biocompatibility, cleaning and disinfection effectiveness, thermal, electrical, electromagnetic, and mechanical safety, and conformity with applicable medical device safety standards. These are general safety and performance checks, not specific clinical performance metrics.

    Therefore, the requested information elements related to acceptance criteria, specific performance metrics, sample sizes for test/training sets, expert qualifications, adjudication methods, MRMC studies, or standalone performance are not present in this 510(k) submission.

    The tables provided (pages 6-26) list the "Indications for Use" for the Vivid S5/S6 system and its various transducers. These tables specify for each clinical application (e.g., Fetal/Obstetrics, Abdominal, Cardiac) and mode of operation (e.g., B-mode, PW Doppler, Color Doppler) whether that combination was:

    • "P" - previously cleared by FDA
    • "N" - a new indication in this submission
    • "E" - added under Appendix E of the Ultrasound Guidance

    These tables clarify the intended uses allowed for the device and its transducers, but they do not contain any quantitative acceptance criteria or reported device performance data. They merely state the cleared usage.

    In summary, the provided document does not contain the specific information requested about acceptance criteria and a study proving those criteria are met for the following reasons:

    1. No Acceptance Criteria and Reported Performance Table: The document explicitly states that no clinical studies were required to support substantial equivalence, focusing instead on non-clinical safety and performance aspects. Therefore, there are no reported performance metrics against specific acceptance criteria.
    2. No Test Set Sample Size and Data Provenance: Since no clinical studies were conducted, there are no test sets or associated provenance information.
    3. No Number of Experts and Qualifications: There is no mention of experts establishing ground truth for test sets, as clinical studies were not performed.
    4. No Adjudication Method: Not applicable as no clinical test set was used requiring adjudication.
    5. No MRMC Comparative Effectiveness Study: No such study was performed or reported.
    6. No Standalone Performance: While the device functions as an algorithm (ultrasound imaging), the submission does not present standalone performance metrics in the context of a study demonstrating its diagnostic effectiveness. It relies on the equivalence to previously cleared devices.
    7. No Type of Ground Truth Used: Not applicable, as there were no clinical studies generating ground truth.
    8. No Sample Size for Training Set: Since this is a hardware device modification and a substantial equivalence claim, it does not involve an AI algorithm with a training set in the conventional sense described for machine learning.
    9. No Ground Truth for Training Set Establishment: Not applicable as there is no mention of a training set for an AI algorithm.

    The submission focuses entirely on demonstrating the safety and effectiveness of the modified device by comparing its technical characteristics and intended uses to those of legally marketed predicate devices, along with adherence to general safety standards.

    Ask a Question

    Ask a specific question about this device

    K Number
    K102393
    Date Cleared
    2010-11-05

    (74 days)

    Product Code
    Regulation Number
    892.1560
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    VIVID S5 DIAGNOSTIC ULTRASOUND SYSTEM; VIVID S6 DIAGNOSTICULTRASOUND SYSTEM

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The device is intended for use by a qualified physician for ultrasound evaluation of Fetal/Obstetrics; Abdominal/Gynecology; Pediatric; Small Organ (breast, testes, thyroid); Neonatal Cephalic; Adult Cephalic; Cardiac (adult and pediatric); Peripheral Vascular; Musculo-skeletal Conventional and Superficial; Urology (including prostate); Transesophageal; Transrectal; Transvaginal; and Intraoperative (abdominal, thoracic, and vascular).

    Device Description

    The Vivid S5 and Vivid S6 are mobile ultrasound consoles having a wide assortment of electronic array transducers intended primarily for echocardiography with additional capability in vascular and general ultrasound imaging. Its intuitive user interface, high level of auto-optimization along with significantly reduced size and weight make it readily maneuverable, efficient and easy to use.

    AI/ML Overview

    Here's a summary of the acceptance criteria and study information for the GE Vivid S5/S6 Diagnostic Ultrasound System, based on the provided text:

    1. Table of Acceptance Criteria and Reported Device Performance

    The provided document (a 510(k) Summary) for the GE Vivid S5/S6 is a premarket notification for a modification to an already legally marketed device. It does not present specific quantitative acceptance criteria or detailed performance metrics in the typical sense of a clinical or analytical performance study. Instead, the "acceptance criteria" are implied through the concept of substantial equivalence to its predicate device (Vivid S5 and Vivid S6 Diagnostic Ultrasound Systems, K092079).

    The reported device performance is that it meets this substantial equivalence:

    Acceptance Criteria (Implied)Reported Device Performance
    Comparable type to predicate deviceThe modified Vivid S5/S6 is of a comparable type to the current Vivid S5/S6.
    Substantially equivalent to predicate deviceThe modified Vivid S5/S6 is substantially equivalent to the current Vivid S5/S6, having the same overall characteristics, key safety and effectiveness features, physical design, construction, materials, and intended uses and operating modes. It also has additional software features similar to other cleared GE Ultrasound systems.
    Conforms with applicable medical device safety standardsThe device has been evaluated for acoustic output, biocompatibility, cleaning and disinfection effectiveness, as well as thermal, electrical, electromagnetic, and mechanical safety, and has been found to conform with applicable medical device safety standards. Compliance is verified through independent evaluation with ongoing factory surveillance.
    Complies with voluntary standardsThe modified Vivid S5/S6 and its applications comply with voluntary standards as detailed in Sections 9, 11, and 17 of the premarket submission.
    Risk analysis conductedRisk analysis conducted.
    Requirements Reviews conductedRequirements Reviews conducted.
    Design Reviews conductedDesign Reviews conducted.
    Testing on unit level (Module verification)Testing on unit level (Module verification) conducted.
    Integration testing (System verification)Integration testing (System verification) conducted.
    Final Acceptance Testing (Validation)Final Acceptance Testing (Validation) conducted.
    Performance testing (Verification)Performance testing (Verification) conducted.
    Safety testing (Verification)Safety testing (Verification) conducted.
    Transducer and patient contact materials are biocompatibleTransducer materials and other patient contact materials are biocompatible.
    Intended uses and key features consistent with clinical practice, FDA guidelines, and established methodsIntended uses and other key features are consistent with traditional clinical practice, FDA guidelines, and established methods of patient examination.
    Design and development process conforms with 21 CFR 820 and ISO13485 quality systemsThe design and development process of the manufacturer conforms with 21 CFR 820, and ISO13485 quality systems.

    2. Sample Size Used for the Test Set and Data Provenance

    The document explicitly states: "The subject of this premarket submission, the modified Vivid S5/S6, did not require clinical studies to support substantial equivalence."

    Therefore, there is no separate "test set" in the context of clinical performance evaluation described here. The evaluation relies on non-clinical tests (acoustic output, biocompatibility, safety, etc.) and comparison to the predicate device.

    3. Number of Experts and Qualifications for Ground Truth

    Not applicable, as no clinical studies requiring expert-established ground truth were performed for this specific submission to demonstrate substantial equivalence.

    4. Adjudication Method

    Not applicable, as no clinical studies requiring adjudication were performed.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    No MRMC comparative effectiveness study was mentioned. The submission focuses on substantial equivalence based on technical specifications and non-clinical testing, not on improved human reader performance with or without AI assistance.

    6. Standalone (Algorithm Only) Performance Study

    Not applicable. This is an ultrasound system, not an AI algorithm intended for standalone performance evaluation in the context of this 510(k) submission. The document mentions "additional software features that are similar to other cleared GE Ultrasound systems," but does not detail any standalone performance studies for these features.

    7. Type of Ground Truth Used

    The "ground truth" for demonstrating substantial equivalence for this device relies on:

    • Compliance with established safety and performance standards: Non-clinical tests (acoustic output, biocompatibility, electrical, thermal, mechanical safety).
    • Comparison to predicate device specifications and performance: The existing cleared Vivid S5/S6 (K092079) serves as the benchmark for "truth" in terms of equivalence.

    8. Sample Size for the Training Set

    Not applicable, as this submission is for an ultrasound system based on established technology and substantial equivalence, not a new AI model requiring a training set.

    9. How the Ground Truth for the Training Set Was Established

    Not applicable, as there is no mention of an AI model training set in this submission.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1